Tamara van Donge

Chapter 9 186 19. McWilliam SJ, Antoine DJ, Sabbisetti V, et al. Reference intervals for urinary renal injury biomarkers KIM-1 and NGAL in healthy children. Biomarkers in medicine. 2014;8(10):1189-1197. 20. Zwiers AJ, Cransberg K, de Rijke YB, et al. Reference ranges for serum β-trace protein in neonates and children younger than 1 year of age. Clinical Chemistry and Laboratory Medicine (CCLM). 2014;52(12):1815-1821. 21. Hilderink JM, van der Linden N, Kimenai DM, et al. Biological variation of creatinine, Cystatin C, and eGFR over 24 Hours. Clinical chemistry. 2018;64(5):851-860. 22. Uemura O, Honda M, Matsuyama T, et al. Age, gender, and body length effects on reference serum creatinine levels determined by an enzymatic method in Japanese children: a multicenter study. Clinical and experimental nephrology. 2011;15(5):694-699. 23. Bennett MR, Ma Q, Ying J, Devarajan P, Brunner H. Effects of age and gender on reference levels of biomarkers comprising the pediatric Renal Activity Index for Lupus Nephritis (p-RAIL). Pediatric Rheumatology. 2017;15(1):74. 24. van den Anker J, Reed MD, Allegaert K, Kearns GL. Developmental changes in pharmacokinetics and pharmacodynamics. The Journal of Clinical Pharmacology. 2018;58:S10-S25. 25. Quigley R. Developmental changes in renal function. Current opinion in pediatrics. 2012;24(2):184- 190. 26. Skinner R. Late renal toxicity of treatment for childhood malignancy: risk factors, long-term outcomes, and surveillance. Pediatric Nephrology. 2018;33(2):215-225. 27. Khosravi N, Asgari M, Khalessi N, Hoseini R, Khosravi N. Serum beta-trace protein for assessment of kidney function in neonates. Iranian journal of kidney diseases. 2018;12(1):11. 28. Allegaert K, Mekahli D, van den Anker J. Cystatin C in newborns: a promising renal biomarker in search for standardization and validation. The Journal of Maternal-Fetal & Neonatal Medicine. 2015;28(15):1833-1838. 29. Saeidi B, Koralkar R, Griffin RL, Halloran B, Ambalavanan N, Askenazi DJ. Impact of gestational age, sex, and postnatal age on urine biomarkers in premature neonates. Pediatric Nephrology. 2015;30(11):2037-2044. 30. Zwiers AJ, de Wildt SN, de Rijke YB, et al. Reference intervals for renal injury biomarkers neutrophil gelatinase-associated lipocalin and kidney injury molecule-1 in young infants. Clinical Chemistry and Laboratory Medicine (CCLM). 2015;53(8):1279-1289. 31. Ikezumi Y, Honda M, Matsuyama T, et al. Establishment of a normal reference value for serum β2 microglobulin in Japanese children: reevaluation of its clinical usefulness. Clinical and experimental nephrology. 2013;17(1):99-105. 32. Cangemi G, Storti S, Cantinotti M, et al. Reference values for urinary neutrophil gelatinase- associated lipocalin (NGAL) in pediatric age measured with a fully automated chemiluminescent platform. Clinical chemistry and laboratory medicine. 2013;51(5):1101-1105. 33. Armangil D, Yurdakök M, Canpolat FE, Korkmaz A, Yiğit Ş, Tekinalp G. Determination of reference values for plasma cystatin C and comparison with creatinine in premature infants. Pediatric Nephrology. 2008;23(11):2081. 34. Finney H, Newman D, Thakkar H, Fell J, Price C. Reference ranges for plasma cystatin C and creatinine measurements in premature infants, neonates, and older children. Archives of disease in childhood. 2000;82(1):71-75. 35. Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC medical research methodology. 2014;14(1):135. 36. Huynh TK, Bateman DA, Parravicini E, et al. Reference values of urinary neutrophil gelatinase- associated lipocalin in very low birth weight infants. Pediatric research. 2009;66(5):528.